[EN] ADAMANTYL DERIVATES AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] DERIVES D'ADAMANTYL UTILISES COMME ANTAGONISTES DU RECEPTEUR P2X7
申请人:ASTRAZENECA AB
公开号:WO2006025783A1
公开(公告)日:2006-03-09
The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
这项发明提供了公式(I)化合物及其药用可接受盐或溶剂化物,其中R1、A1、m和A如规范中定义;它们的制备方法;含有它们的药物组合物;以及它们在治疗中的应用。